Literature DB >> 24767385

Ocular manifestations of patients receiving heart transplants: a single-center experience of 311 consecutive cases.

C-C Su1, J-W Chen2, N-K Chou2, Y-S Chen2, S-C Huang2, N-H Chi2, S-S Wang3.   

Abstract

PURPOSE: The purpose of this study was to investigate ocular manifestations of patients undergoing heart transplantations.
METHOD: We retrospectively reviewed the clinical data of 311 patients who underwent orthotropic heart transplantations from January 1989 to December 2007, including the demographic data, general conditions, medications, as well as the basic ophthalmic examinations, ophthalmic diagnosis, and management.
RESULTS: Of the 311 heart transplant recipients, common diagnoses included cataract (96 cases; 30.87%), dry eye syndrome (24 cases; 7.72%), allergic conjunctivitis (78 cases; 25.08%), and glaucoma (19 cases; 6.11%). The patients after heart transplantation had much lower incidences of severe opportunistic infections than patients undergoing the same procedure one decade ago. However, autoimmune-related endocrinopathy such as diabetes and Graves' disease became more prevalent. Diabetes-related complications were unexpectedly frequent, including nonproliferative diabetic retinopathy (6 cases; 1.93%), proliferative diabetic retinopathy (6 cases; 1.93%), retinal vein occlusion (6 cases; 1.93%), and neovascular glaucoma (4 cases; 1.29%). The occurrence of cataract formation and steroid glaucoma was often due to post-transplantation steroid use.
CONCLUSION: Ophthalmologists and cardiac surgeons should collaborate and perform regular ophthalmic examinations, especially for those who have new-onset diabetes and difficulty tapering off steroids.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24767385     DOI: 10.1016/j.transproceed.2013.11.149

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  1 in total

1.  Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids.

Authors:  Elon H C van Dijk; Darius Soonawala; Vera Rooth; Carel B Hoyng; Onno C Meijer; Aiko P J de Vries; Camiel J F Boon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-23       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.